Limited Offer
Heart failure with reduced ejection fraction, An Issue of Cardiology Clinics
- 1st Edition, Volume 41-4 - September 26, 2023
- Editor: Asad Ghafoor
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 1 8 1 9 5 - 5
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 8 1 9 6 - 2
In this issue of Cardiology Clinics, guest editor Dr. Asad Ghafoor brings his considerable expertise to the topic of Heart Failure with Reduced Ejection Fraction. Top experts in… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteIn this issue of Cardiology Clinics, guest editor Dr. Asad Ghafoor brings his considerable expertise to the topic of Heart Failure with Reduced Ejection Fraction. Top experts in the field cover issues such as choosing temporary mechanical support in cardiogenic shock; sequencing in quadruple therapy for HFrEF; the war against heart failure hospitalizations: remote monitoring and the case for expanding criteria; the uncertain benefit from ICDs in nonischemic cardiomyopathy; frailty and its spectrum of implications in HFrEF; and more.
- Contains 12 relevant, practice-oriented topics including HFrEF and COVID-19: when the sick get sicker–unmasking health inequities during a pandemic; obesity in heart failure; goals for prevention versus treating HFrEF with modern tech; the economic burden of HFrEF: living longer but poorer?; and more.
- Provides in-depth clinical reviews on heart failure with reduced ejection fraction, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Cardiology
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- Preface
- Heart Failure with Reduced Ejection Fraction and COVID-19, when the Sick Get Sicker: Unmasking Racial and Ethnic Inequities During a Pandemic
- Key points
- Introduction
- Steps to address barriers
- Summary
- Clinics care points
- Funding
- The Economic Burden of Heart Failure with Reduced Ejection Fraction: Living Longer but Poorer?
- Key points
- Chronic diseases are costly
- Heart failure with reduced ejection fraction is a prototype for chronic disease
- Hyper-polypharmacy
- Societal costs
- Patient costs
- Out-of-pocket medication costs
- Caregiver costs
- Indirect costs
- Efforts to consider value in clinical practice guidelines and policy recommendations
- Integrating patient cost into medical decision making
- Health policy and payment
- Summary
- Clinics care points
- Disclosures
- Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?
- Key points
- Introduction
- Tolerability, safety, and efficacy
- Renin–Angiotensin System Inhibitors
- Beta blockers
- Mineralocorticoid receptor antagonists
- Sodium–glucose cotransporter 2 inhibitors
- Guideline-directed medical therapy sequencing in special populations
- Summary
- Clinics care points
- Disclosure
- Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction: Impact on Prognosis and Treatment
- Key points
- Underlying mechanisms of frailty in heart failure
- Assessment of frailty
- Clinical profile
- Prognosis and outcomes
- Efficacy of heart failure therapies in patients with frailty
- A multi-domain approach to frailty in heart failure
- Summary
- Clinics care points
- Financial disclosures
- Obesity in Heart Failure with Reduced Ejection Fraction: Time to Address the Elephant in the Room
- Key points
- Introduction
- Challenges with definitions of obesity in heart failure with reduced ejection fraction
- Can obesity cause heart failure with reduced ejection fraction?
- Pathophysiology of heart failure with reduced ejection fraction and obesity
- Impact of obesity on symptoms in heart failure with reduced ejection fraction
- Obesity and its association with outcomes in heart failure with reduced ejection fraction: The misleading statistical obesity paradox
- Treatment implications of obesity in heart failure with reduced ejection fraction
- Clinics care points
- Disclosure
- Funding
- The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy: How to Guide Clinical Decision-Making?
- Key points
- Introduction
- Summary
- Clinics care points
- Funding
- Disclosures
- The War Against Heart Failure Hospitalizations: Remote Monitoring and the Case for Expanding Criteria
- Key points
- Introduction
- Remote evaluation of vital signs and symptoms
- Invasive hemodynamic monitoring: facts and current concepts
- Remote pulmonary artery pressure monitoring
- Cardiac implantable electronic devices
- The case for expansion of indication criteria
- Emerging technology in the remote monitoring arena
- Summary
- Clinics care points
- Disclosure
- Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies: Do They Have a Role in Advanced Heart Failure with Reduced Ejection Fraction?
- Key points
- Introduction
- Discussion
- Future directions
- Summary
- Clinics care points
- Disclosures
- Guide to Temporary Mechanical Support in Cardiogenic Shock: Choosing Wisely
- Key points
- Introduction
- Left ventricle support systems
- Right ventricle support systems
- Biventricular support systems
- Summary
- Clinics care points
- Disclosure
- When all Else Fails, Try This: The HeartMate III Left Ventricle Assist Device
- Key points
- Introduction
- Patient selection and timing
- Indications and contraindications for left ventricle assist device therapy
- Outcomes after left ventricle assist device implant
- Adverse events
- Summary
- Clinics care points
- Disclosure
- No. of pages: 240
- Language: English
- Edition: 1
- Volume: 41-4
- Published: September 26, 2023
- Imprint: Elsevier
- Hardback ISBN: 9780443181955
- eBook ISBN: 9780443181962
AG
Asad Ghafoor
Affiliations and expertise
Program Director – Advance Heart Failure & Transplant Cardiology Fellowship, Aurora St. Luke's Medical Center